The focus of a recent hearing of Senate Health, Education, Labor and Pensions (HELP) was the FDA's user fee agreements, or monies the agency receives from drug and medical device manufacturers to accelerate the review process.
Trending:
Senate Health Committee Heats Up Over Lack of AHCA Discussion